Aurobindo Pharma Ltd
NSE: AUROPHARMA BSE: 524804
₹1705
+10.50 (0.62%)
Fri, 06 Nov 2026, 10:01 pm
Market Cap (in Cr)97756.7
PE Ratio26.64
Dividend0.24
Health Technology
Pharmaceuticals: Other
24.5KAurobindo Pharma Peer Comparison
Aurobindo Pharma Ltd
Laurus Labs Ltd
Divis Laboratories Ltd
Zydus Lifesciences Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
| Company Name | Debt to Equity | EV/EBITDA | Industry ROCE % | Industry RONW % | P/B | P/E | ROCE % | ROE % |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | 0.23 | 10.16 | 12.29 | 10.69 | 2 | 21.60 | 12.43 | 9.93 |
| Torrent Pharmaceuticals Ltd | 1.14 | 35.81 | 14.50 | 13.64 | 17.03 | 66.03 | 18.30 | 26.76 |
| Sun Pharmaceutical Industries Ltd | 0.04 | 22.54 | 12.29 | 10.69 | 5.05 | 36.73 | 18.72 | 14.85 |
| Zydus Lifesciences Ltd | 0.31 | 11.66 | 12.29 | 10.69 | 3.23 | 17.39 | 20.30 | 19.69 |
| Divis Laboratories Ltd | 0 | 39.79 | 14.36 | 12.13 | 9.40 | 61.36 | 21 | 16.19 |
| Laurus Labs Ltd | 0.54 | 30.53 | 12.29 | 10.69 | 10.10 | 60.26 | 16.70 | 18.21 |
